Home » Stocks » BSTG

Biostage, Inc. (BSTG)

Stock Price: $1.63 USD 0.00 (0.00%)
Updated Mar 5, 2021 10:47 AM EST - Market closed
Market Cap 15.30M
Revenue (ttm) n/a
Net Income (ttm) -5.44M
Shares Out 8.86M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $1.63
Previous Close $1.63
Change ($) 0.00
Change (%) 0.00%
Day's Open 1.63
Day's Range 1.63 - 1.63
Day's Volume 217
52-Week Range 0.8 - 4.88

News

There are no news available yet.

About BSTG

Biostage, a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquarte... [Read more...]

Industry
Biotechnology
Founded
2007
Stock Exchange
OTCMKTS
Ticker Symbol
BSTG
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Biostage is 3.00, which is an increase of 84.05% from the latest price.

Price Target
$3.00
(84.05% upside)